Natural killer (NK) cells and killer (K) cells mediating antibody-dependent cellular cytotoxicity have been shown to be large granular lymphocytes (LGLs). Studies are proceeding to define the receptors and structures involved in NK recognition. A monoclonal antibody (MoAb) was developed against NK target antigens on K562 cells and that antibody blocked LGL binding and lysis. We also developed an anti-idiotypic antibody (anti-ID) against this MoAb anticipating that it might recognize the NK receptor and aid in its identification. This anti-ID antibody is reactive with an effector cell protein and blocks LGLs binding and target cell lysis. Utilizing this anti-ID, an expression library from CD3- LGL was screened and specific cDNA clones were isolated and sequenced. Based on the predicted protein sequence, the cDNA was found to code for a unique 1016 AA protein that consisted of several distinct structural domains. The NH2- terminal domain was 50% homologous to cyclophilin, a cyclosporin binding protein. This was followed by the idiotype region, a transmembrane domain, and a 367 AA cytoplasmic domain. Studies are presently underway to further characterize and unequivocally demonstrate the receptor nature of this unique gene.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Intramural Research (Z01)
Project #
1Z01CM009247-10
Application #
3874506
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
10
Fiscal Year
1990
Total Cost
Indirect Cost
Name
Division of Cancer Treatment
Department
Type
DUNS #
City
State
Country
United States
Zip Code